Epidemiological update: Ongoing outbreak of cholera in Cuba, potential risk for European travellersArchived
On 3 July the Cuban Ministry of Health confirmed an outbreak of cholera in the south-western city of Manzanillo. It is the first time in almost 150 years that an outbreak of cholera is reported in the island.
Risk of travel-associated cholera transmission can remain low if precautionary measures are takenArchived
ECDC has issued a risk assessment on cholera transmission related to travel to the Dominican Republic after two cases have been detected in tourists returning to the UK and Germany from resorts in the Punta Cana area of the Dominican Republic.
Panton-Valentine leukocidin-positive Staphylococcus aureus infections in returning travelersArchived
The authors present data on 15 individuals infected by Panton-Valentine leukocidin (PVL) -producing strains of Staphylococcus aureus. Intra-familial spread was documented in one case, and occupational transmission was most likely in another case. spa typing of the strains revealed a broad range of variants, though some strains were clonally related. Methicillin-resistant Staphylococcus aureus (MRSA) was found in three cases.
Imported methicillin-resistant Staphylococcus aureus, SwedenArchived
The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East.
Significant increase in travel associated Dengue Fever in GermanyArchived
Few and limited occasions of dengue virus transmission have recently been reported in Europe, which were not unexpected considering the presence of the vector Aedes albopictus
Protracted rheumatic manifestations in travelersArchived
This paper describes a small retrospective observational study of Israeli travellers presenting to a tropical medicine clinic with a history of prolonged (4 weeks), non-traumatic arthralgia or arthritis over a 5 year period.